{"id":"https://openalex.org/W7214950238","doi":"https://doi.org/10.26434/chemrxiv.15006651/v2","title":"In silico evaluation of novel isosteres against PTPN1 and estrogen receptor alpha: molecular docking, ADMET profiling, and quantum chemical analysis","display_name":"In silico evaluation of novel isosteres against PTPN1 and estrogen receptor alpha: molecular docking, ADMET profiling, and quantum chemical analysis","publication_year":2026,"publication_date":"2026-09-29","ids":{"openalex":"https://openalex.org/W7214950238","doi":"https://doi.org/10.26434/chemrxiv.15006651/v2"},"language":"en","primary_location":{"id":"doi:10.26434/chemrxiv.15006651/v2","doi":"https://doi.org/10.26434/chemrxiv.15006651/v2","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.15006651/v2","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.26434/chemrxiv.15006651/v2","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5140222801","display_name":"Lilian Rouille","orcid":"https://orcid.org/0009-0001-1415-0187","observed_orcids":["https://orcid.org/0009-0001-1415-0187"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Lilian Rouille","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-1415-0187","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5140222801"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ptp1b","display_name":"PTP1B","score":0.9179999828338623},{"id":"https://openalex.org/keywords/estrogen-receptor-alpha","display_name":"estrogen receptor alpha","score":0.8529999852180481},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.5109999775886536},{"id":"https://openalex.org/keywords/admet-prediction","display_name":"ADMET prediction","score":0.9070000052452087},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibition","display_name":"cytochrome P450 inhibition","score":0.9629999995231628},{"id":"https://openalex.org/keywords/blood-brain-barrier-permeability","display_name":"blood-brain barrier permeability","score":0.8119999766349792},{"id":"https://openalex.org/keywords/electrostatic-potential","display_name":"electrostatic potential","score":0.6370000243186951},{"id":"https://openalex.org/keywords/frontier-molecular-orbitals","display_name":"frontier molecular orbitals","score":0.8849999904632568},{"id":"https://openalex.org/keywords/lead-candidate-selection","display_name":"lead candidate selection","score":0.531000018119812},{"id":"https://openalex.org/keywords/synthetic-accessibility","display_name":"synthetic accessibility","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.79339998960495},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7427999973297119},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.6363999843597412},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4862000048160553},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.42160001397132874},{"id":"https://openalex.org/C103697762","wikidata":"https://www.wikidata.org/wiki/Q4112105","display_name":"Virtual screening","level":3,"score":0.4016000032424927},{"id":"https://openalex.org/C172313692","wikidata":"https://www.wikidata.org/wiki/Q14902310","display_name":"Estrogen receptor alpha","level":5,"score":0.40059998631477356},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.400299996137619},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.3686999976634979},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.36570000648498535},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.3587000072002411},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3366999924182892},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.33090001344680786},{"id":"https://openalex.org/C85528070","wikidata":"https://www.wikidata.org/wiki/Q643602","display_name":"Protein tyrosine phosphatase","level":3,"score":0.3273000121116638},{"id":"https://openalex.org/C59593255","wikidata":"https://www.wikidata.org/wiki/Q901663","display_name":"Molecular dynamics","level":2,"score":0.31630000472068787},{"id":"https://openalex.org/C65556437","wikidata":"https://www.wikidata.org/wiki/Q766195","display_name":"Protein Data Bank (RCSB PDB)","level":2,"score":0.3037000000476837},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.29600000381469727},{"id":"https://openalex.org/C11804247","wikidata":"https://www.wikidata.org/wiki/Q896177","display_name":"Protein\u2013protein interaction","level":2,"score":0.2957000136375427},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.27730000019073486},{"id":"https://openalex.org/C169627665","wikidata":"https://www.wikidata.org/wiki/Q5767913","display_name":"Homology modeling","level":3,"score":0.2709999978542328},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.2669999897480011},{"id":"https://openalex.org/C47701112","wikidata":"https://www.wikidata.org/wiki/Q735188","display_name":"Protein structure","level":2,"score":0.2646999955177307},{"id":"https://openalex.org/C147597530","wikidata":"https://www.wikidata.org/wiki/Q369472","display_name":"Computational chemistry","level":1,"score":0.263700008392334},{"id":"https://openalex.org/C2777752112","wikidata":"https://www.wikidata.org/wiki/Q903238","display_name":"Lead compound","level":3,"score":0.2590000033378601}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.26434/chemrxiv.15006651/v2","doi":"https://doi.org/10.26434/chemrxiv.15006651/v2","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.15006651/v2","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.26434/chemrxiv.15006651/v2","doi":"https://doi.org/10.26434/chemrxiv.15006651/v2","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.15006651/v2","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7171503871","https://openalex.org/W2110634434","https://openalex.org/W4414710193","https://openalex.org/W7213391512","https://openalex.org/W4403634402","https://openalex.org/W4328015238","https://openalex.org/W4206062058","https://openalex.org/W7215362920","https://openalex.org/W7111862451","https://openalex.org/W7100389672"],"abstract_inverted_index":{"A":[0],"series":[1],"of":[2,66,87,93,108,188,206,215,290,330],"novel":[3],"cyclic":[4],"alkene":[5],"template":[6],"(CAT)":[7],"isosteres":[8],"(CAT-0":[9],"to":[10,59,149,243,259,324],"CAT-7)":[11],"were":[12,57,72,116],"designed":[13,68,220],"and":[14,37,52,77,83,114,143,163,178,198,211,238,245,280,297,318],"evaluated":[15],"through":[16,91,310],"an":[17],"integrated":[18],"in":[19,139,151,194,207],"silico":[20,208],"workflow":[21],"combining":[22,230],"molecular":[23,311],"docking,":[24],"density":[25],"functional":[26],"theory":[27],"(DFT)":[28],"based":[29,123],"electronic":[30],"structure":[31,134],"analysis,":[32],"ADMET":[33,162,209,299],"prediction,":[34],"CYP450":[35,181],"profiling,":[36],"preliminary":[38],"synthetic":[39,240,254],"feasibility":[40,282],"assessment.":[41],"Two":[42],"biologically":[43],"relevant":[44],"protein":[45,47],"targets,":[46],"tyrosine":[48],"phosphatase":[49],"1B":[50],"(PTPN1)":[51],"estrogen":[53],"receptor":[54,295],"alpha":[55],"(ER\u03b1/ESR1),":[56],"investigated":[58],"explore":[60],"the":[61,67,75,88,94,106,109,119,130,155,158,203,219,225,272,284,288,326,331],"potential":[62,141],"biological":[63,278,328],"activity":[64,279],"profiles":[65],"compounds.":[69],"Docking":[70],"studies":[71],"performed":[73],"using":[74],"2HNP":[76],"3ERT":[78],"crystal":[79],"structures":[80],"for":[81],"PTPN1":[82],"ER\u03b1,":[84],"respectively.":[85],"Validation":[86],"docking":[89,110,232],"protocols":[90],"reproduction":[92],"corresponding":[95],"co-crystallized":[96],"ligand":[97],"poses":[98],"yielded":[99],"RMSD":[100],"values":[101],"below":[102],"2":[103],"\u00c5,":[104],"supporting":[105,157],"reliability":[107],"procedures.":[111],"CAT-3,":[112],"CAT-4,":[113],"CAT-7":[115],"identified":[117],"as":[118,224,265,306],"most":[120,172,226,273],"promising":[121,267],"candidates":[122],"on":[124],"their":[125],"predicted":[126,180,235,250,277,327],"binding":[127,152],"affinities":[128],"across":[129],"two":[131],"targets.":[132],"Electronic":[133],"analysis":[135],"suggested":[136],"that":[137],"variations":[138],"electrostatic":[140],"distribution":[142],"frontier":[144],"orbital":[145],"characteristics":[146],"may":[147],"contribute":[148],"differences":[150],"behavior":[153],"within":[154,283],"series,":[156],"isosteric":[159],"design":[160],"strategy.":[161],"toxicity":[164,200],"predictions":[165,210],"indicated":[166],"generally":[167],"favorable":[168,231,274],"drug-like":[169],"properties,":[170,237],"with":[171],"compounds":[173],"exhibiting":[174],"acceptable":[175,234],"gastrointestinal":[176],"absorption":[177],"low":[179],"inhibitory":[182],"activity,":[183],"suggesting":[184],"a":[185,266],"limited":[186],"risk":[187],"CYP-mediated":[189],"drug\u2013drug":[190],"interactions.":[191],"However,":[192],"variability":[193],"blood\u2013brain":[195],"barrier":[196],"permeability":[197],"model-dependent":[199],"endpoints":[201],"highlights":[202],"inherent":[204],"uncertainty":[205],"warrants":[212],"cautious":[213],"interpretation":[214],"absolute":[216],"values.":[217],"Among":[218],"compounds,":[221],"CAT-3":[222,270],"emerged":[223],"balanced":[227],"lead":[228],"candidate,":[229],"performance,":[233],"pharmacokinetic":[236],"improved":[239],"accessibility":[241],"relative":[242],"CAT-4":[244],"CAT-7,":[246],"which,":[247],"despite":[248],"strong":[249],"affinities,":[251],"present":[252],"greater":[253],"constraints.":[255],"Its":[256],"structural":[257],"relationship":[258],"trodusquemine":[260],"further":[261],"supports":[262],"its":[263],"relevance":[264,329],"scaffold.":[268],"Overall,":[269],"represents":[271],"compromise":[275],"between":[276],"practical":[281],"series.":[285,333],"Nevertheless,":[286],"given":[287],"limitations":[289],"empirical":[291],"scoring":[292],"functions,":[293],"rigid":[294],"approximations,":[296],"predictive":[298],"models,":[300],"these":[301],"findings":[302],"should":[303],"be":[304,322],"regarded":[305],"hypothesis-generating.":[307],"Further":[308],"validation":[309],"dynamics":[312],"simulations,":[313],"MM-GBSA":[314],"free":[315],"energy":[316],"calculations,":[317],"experimental":[319],"assays":[320],"will":[321],"required":[323],"confirm":[325],"CAT":[332]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-01T00:00:00"}